Advanced search
Publication Cover
Dialogues in Clinical Neuroscience Volume 11, 2009 - Issue 4
Submit an article Journal homepage
1,464
Views
51
CrossRef citations to date
0
Altmetric
Clinical Research

A new paradigm for the prediction of antidepressant treatment response

Un nuevo paradigma para predecir la respuesta al tratamiento antidepresivo

Un nouweau paradigme de prédiction de la réponse au traitement antidépresseur

Andrew F. LeuchterLaboratory of Brain Behavior, and Pharmacology, and the Depression Research and Clinical Program, Semel Institute for Neuroscience and Human Behavior at UCLA, and the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, California, USACorrespondence[email protected]
,
Ian A. CookLaboratory of Brain Behavior, and Pharmacology, and the Depression Research and Clinical Program, Semel Institute for Neuroscience and Human Behavior at UCLA, and the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, California, USA
,
Aimee M. HunterLaboratory of Brain Behavior, and Pharmacology, and the Depression Research and Clinical Program, Semel Institute for Neuroscience and Human Behavior at UCLA, and the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, California, USA
&
Alexander S. KorbLaboratory of Brain Behavior, and Pharmacology, and the Depression Research and Clinical Program, Semel Institute for Neuroscience and Human Behavior at UCLA, and the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, California, USA
Pages 435-446 | Published online: 01 Apr 2022

Citations (51)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (7)

Takeshi Inoue, Shinji Fujimoto, Tatsuro Marumoto, Tadayuki Kitagawa, Kazuyuki Ishida, Tadashi Nakajima, Yoshiya Moriguchi, Keita Fujikawa & Koichiro Watanabe. (2021) Early Improvement with Vortioxetine Predicts Response and Remission: A Post Hoc Analysis of Data from a Clinical Trial Conducted in Japan. Neuropsychiatric Disease and Treatment 17, pages 3735-3741.
Read now
Marguerite Le Marois, Eleni Tzavara, El Chérif Ibrahim, Olivier Blin & Raoul Belzeaux. (2021) RNA therapeutics for mood disorders: current evidence toward clinical trials. Expert Opinion on Investigational Drugs 30:7, pages 721-736.
Read now
Serafim Carvalho, Filipa Caetano, José Pinto-Gouveia, Jorge Mota-Pereira, Dulce Maia, Paulo Pimentel, Cátia Priscila & Paul Gilbert. (2021) Predictors of poor 6-week outcome in a cohort of major depressive disorder patients treated with antidepressant medication: the role of entrapment. Nordic Journal of Psychiatry 75:1, pages 38-48.
Read now
Andrew F. Leuchter, Aimee M. Hunter, David E. Krantz & Ian A. Cook. (2014) Intermediate phenotypes and biomarkers of treatment outcome in major depressive disorder. Dialogues in Clinical Neuroscience 16:4, pages 525-537.
Read now
Sibylle Delaloye & Paul E. Holtzheimer. (2014) Deep brain stimulation in the treatment of depression. Dialogues in Clinical Neuroscience 16:1, pages 83-91.
Read now
Tania Nikolcheva, Stephan Jäger, Theresa Ambrose Bush & Gabriel Vargas. (2011) Challenges in the development of companion diagnostics for neuropsychiatric disorders. Expert Review of Molecular Diagnostics 11:8, pages 829-837.
Read now
Dan Vlad Iosifescu. (2011) Electroencephalography-Derived Biomarkers of Antidepressant Response. Harvard Review of Psychiatry 19:3, pages 144-154.
Read now

Articles from other publishers (44)

Ke Han, Lei Ji, Qinglian Xie, Liangjie Liu, Xi Wu, Lin He, Yi Shi, Rong Zhang, Guang He, Zaiquan Dong & Tao Yu. (2023) Different roles of microbiota and genetics in the prediction of treatment response in major depressive disorder. Journal of Psychiatric Research 161, pages 402-411.
Crossref
Haitham Salem, Tung Huynh, Natasha Topolski, Benson Mwangi, Madhukar H. Trivedi, Jair C. Soares, A. John Rush & Sudhakar Selvaraj. (2023) Temporal multi-step predictive modeling of remission in major depressive disorder using early stage treatment data; STAR*D based machine learning approach. Journal of Affective Disorders 324, pages 286-293.
Crossref
Mark S. George, Kevin A. Caulfield & Melanie Wiley. 2022. Neuroplasticity - From Bench to Bedside. Neuroplasticity - From Bench to Bedside 497 507 .
Akiva Kleinerman, Ariel Rosenfeld, David Benrimoh, Robert Fratila, Caitrin Armstrong, Joseph Mehltretter, Eliyahu Shneider, Amit Yaniv-Rosenfeld, Jordan Karp, Charles F. Reynolds, Gustavo Turecki & Adam Kapelner. (2021) Treatment selection using prototyping in latent-space with application to depression treatment. PLOS ONE 16:11, pages e0258400.
Crossref
Rita Vieira, Ana Coelho, Joana Reis, Carlos Portugal-Nunes, Ricardo Magalhães, Sónia Ferreira, Pedro Silva Moreira, Nuno Sousa & João M. Bessa. (2021) White Matter Microstructure Alterations Associated With Paroxetine Treatment Response in Major Depression. Frontiers in Behavioral Neuroscience 15.
Crossref
Mohsen Sadat Shahabi, Ahmad Shalbaf & Arash Maghsoudi. (2021) Prediction of drug response in major depressive disorder using ensemble of transfer learning with convolutional neural network based on EEG. Biocybernetics and Biomedical Engineering 41:3, pages 946-959.
Crossref
Marco A. MINETTO, Chiara BUSSO, Alessandro GIANNINI, Kristen MEIBURGER, Giuseppe MASSAZZA & Nicola MAFFULLI. (2021) Cross-cultural adaptation and validation of the Victorian Institute of Sports Assessment for gluteal tendinopathy questionnaire in Italian and investigation of the association between tendinopathy-related disability and pain. European Journal of Physical and Rehabilitation Medicine 56:6.
Crossref
Kristina Chechotka, Emina Bajrovic & Anne Gross. 2021. Blood and Marrow Transplant Handbook. Blood and Marrow Transplant Handbook 675 689 .
Klaus Munkholm, Stephanie Winkelbeiner & Philipp Homan. (2020) Individual response to antidepressants for depression in adults-a meta-analysis and simulation study. PLOS ONE 15:8, pages e0237950.
Crossref
Tony Olmert, Jason D Cooper, Sung Yeon Sarah Han, Giles Barton-Owen, Lynn Farrag, Emily Bell, Lauren V Friend, Sureyya Ozcan, Nitin Rustogi, Rhian L Preece, Pawel Eljasz, Jakub Tomasik, Daniel Cowell & Sabine Bahn. (2020) A Combined Digital and Biomarker Diagnostic Aid for Mood Disorders (the Delta Trial): Protocol for an Observational Study. JMIR Research Protocols 9:8, pages e18453.
Crossref
Harold A. Sackeim, Scott T. Aaronson, Mark T. Bunker, Charles R. Conway, Mark A. Demitrack, Mark S. George, Joan Prudic, Michael E. Thase & A. John Rush. (2019) The assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form (ATHF-SF). Journal of Psychiatric Research 113, pages 125-136.
Crossref
Yuhao Xu, Hong Wei, Yuanyuan Zhu, Yan Zhu, Ningning Zhang, Jiasheng Qin, Xiaolan Zhu, Ming Yu & Yuefeng Li. (2019) Potential serum biomarkers for the prediction of the efficacy of escitalopram for treating depression. Journal of Affective Disorders 250, pages 307-312.
Crossref
Kelly Perlman, David Benrimoh, Sonia Israel, Colleen Rollins, Eleanor Brown, Jingla-Fri Tunteng, Raymond You, Eunice You, Myriam Tanguay-Sela, Emily Snook, Marc Miresco & Marcelo T. Berlim. (2019) A systematic meta-review of predictors of antidepressant treatment outcome in major depressive disorder. Journal of Affective Disorders 243, pages 503-515.
Crossref
Aamir Saeed Malik & Wajid Mumtaz. 2019. EEG-Based Experiment Design for Major Depressive Disorder. EEG-Based Experiment Design for Major Depressive Disorder 1 20 .
Aimee M. Hunter, Thien X. Nghiem, Ian A. Cook, David E. Krantz, Michael J. Minzenberg & Andrew F. Leuchter. (2017) Change in Quantitative EEG Theta Cordance as a Potential Predictor of Repetitive Transcranial Magnetic Stimulation Clinical Outcome in Major Depressive Disorder. Clinical EEG and Neuroscience 49:5, pages 306-315.
Crossref
Stefanie Wagner, Isabella Helmreich, Daniel Wollschläger, Konstantin Meyer, Sabine Kaaden, Julia Reiff, Sibylle C. Roll, Dieter Braus, Oliver Tüscher, Florian Müller-Dahlhaus, André Tadić & Klaus Lieb. (2018) Early improvement of executive test performance during antidepressant treatment predicts treatment outcome in patients with Major Depressive Disorder. PLOS ONE 13:4, pages e0194574.
Crossref
Julia-Lou Consoloni, El Chérif Ibrahim, Marie-Noëlle Lefebvre, Xavier Zendjidjian, Emilie Olié, Pascale Mazzola-Pomietto, Thomas Desmidt, Ludovic Samalin, Pierre-Michel Llorca, Mocrane Abbar, Jorge Lopez-Castroman, Emmanuel Haffen, Karine Baumstarck, Jean Naudin, Jean-Michel Azorin, Wissam El-Hage, Philippe Courtet & Raoul Belzeaux. (2018) Serotonin transporter gene expression predicts the worsening of suicidal ideation and suicide attempts along a long-term follow-up of a Major Depressive Episode. European Neuropsychopharmacology 28:3, pages 401-414.
Crossref
Stefanie Wagner, Alice Engel, Jan Engelmann, David Herzog, Nadine Dreimüller, Marianne B. Müller, André Tadić & Klaus Lieb. (2017) Early improvement as a resilience signal predicting later remission to antidepressant treatment in patients with Major Depressive Disorder: Systematic review and meta-analysis. Journal of Psychiatric Research 94, pages 96-106.
Crossref
Tabitha A. Iseger, Mayuresh S. Korgaonkar, J. Leon Kenemans, Stuart M. Grieve, Chris Baeken, Paul B. Fitzgerald & Martijn Arns. (2017) EEG connectivity between the subgenual anterior cingulate and prefrontal cortices in response to antidepressant medication. European Neuropsychopharmacology 27:4, pages 301-312.
Crossref
Hassan Rahmoune, Daniel Martins-de-Souza & Paul C. Guest. 2017. Proteomic Methods in Neuropsychiatric Research. Proteomic Methods in Neuropsychiatric Research 69 84 .
Man K. Chan, Jason D. Cooper, Mariska Bot, Tom K. Birkenhager, Veerle Bergink, Hemmo A. Drexhage, Johann Steiner, Matthias Rothermundt, Brenda W.J.H. Penninx & Sabine Bahn. (2016) Blood-based immune-endocrine biomarkers of treatment response in depression. Journal of Psychiatric Research 83, pages 249-259.
Crossref
Marlene P. Freeman, Maurizio Fava, Carl Gommoll, Changzheng Chen, William M. Greenberg & Adam Ruth. (2016) Effects of levomilnacipran ER on fatigue symptoms associated with major depressive disorder. International Clinical Psychopharmacology 31:2, pages 100-109.
Crossref
Mahdi Mohammadi, Fadwa Al-Azab, Bijan Raahemi, Gregory Richards, Natalia Jaworska, Dylan Smith, Sara de la Salle, Pierre Blier & Verner Knott. (2015) Data mining EEG signals in depression for their diagnostic value. BMC Medical Informatics and Decision Making 15:1.
Crossref
Aimee M. Hunter, Ian A. Cook, Molly Tartter, Simi K. Sharma, Gregory D. Disse & Andrew F. Leuchter. (2015) Antidepressant treatment history and drug-placebo separation in a placebo-controlled trial in major depressive disorder. Psychopharmacology 232:20, pages 3833-3840.
Crossref
Man K. Chan, Michael G. Gottschalk, Frieder Haenisch, Jakub Tomasik, Tillmann Ruland, Hassan Rahmoune, Paul C. Guest & Sabine Bahn. (2014) Applications of blood-based protein biomarker strategies in the study of psychiatric disorders. Progress in Neurobiology 122, pages 45-72.
Crossref
Catherine J. Harmer. (2014) Neural Predictors of Treatment Response in Depression. Current Behavioral Neuroscience Reports 1:3, pages 125-133.
Crossref
Romain Icick, Élodie Millet, Emmanuel Curis, Frank Bellivier & Jean-Pierre Lépine. (2014) Predictive value of baseline resistance in early response to antidepressants. Journal of Affective Disorders 161, pages 127-135.
Crossref
Seth C. Hopkins, David S. Reasner & Kenneth S. Koblan. (2013) Catechol-O-methyltransferase genotype as modifier of superior responses to venlafaxine treatment in major depressive disorder. Psychiatry Research 208:3, pages 285-287.
Crossref
Diane B. Miller & James P. O'Callaghan. (2013) Personalized medicine in major depressive disorder — Opportunities and pitfalls. Metabolism 62, pages S34-S39.
Crossref
Ross J. BaldessariniRoss J. Baldessarini. 2013. Chemotherapy in Psychiatry. Chemotherapy in Psychiatry 155 250 .
Aimee M. Hunter, Ian A. Cook & Andrew F. Leuchter. (2012) Does prior antidepressant treatment of major depression impact brain function during current treatment?. European Neuropsychopharmacology 22:10, pages 711-720.
Crossref
Ryouhei Ishii & Leonides Canuet. (2012) Heartbeat evoked potentials: A new possible clinical biomarker for depression based on the somatic marker hypothesis. Clinical Neurophysiology 123:10, pages 1899-1900.
Crossref
Anusha Baskaran, Roumen Milev & Roger S. McIntyre. (2012) The neurobiology of the EEG biomarker as a predictor of treatment response in depression. Neuropharmacology 63:4, pages 507-513.
Crossref
Eric W. Klee, Henning Schneider, Karl J. Clark, Margot A. Cousin, Jon O. Ebbert, W. Michael Hooten, Victor M. Karpyak, David O. Warner & Stephen C. Ekker. (2011) Zebrafish: a model for the study of addiction genetics. Human Genetics 131:6, pages 977-1008.
Crossref
Stephan Zschocke & Hans-Christian Hansen. 2012. Klinische Elektroenzephalographie. Klinische Elektroenzephalographie 381 396 .
André Tadić, Stefanie Wagner, Stanislav Gorbulev, Norbert Dahmen, Christoph Hiemke, Dieter F Braus & Klaus Lieb. (2011) Peripheral blood and neuropsychological markers for the onset of action of antidepressant drugs in patients with Major Depressive Disorder. BMC Psychiatry 11:1.
Crossref
Aimee M. Hunter, Ian A. Cook, Scott D. Greenwald, Melody L. Tran, Kate N. Miyamoto & Andrew F. Leuchter. (2011) The Antidepressant Treatment Response Index and Treatment Outcomes in a Placebo-Controlled Trial of Fluoxetine. Journal of Clinical Neurophysiology 28:5, pages 478-482.
Crossref
Cecilio Lopez-Munoz & Francisco AlamoStephan Moratti, Alberto Fernández & Gabriel Rubio. 2011. Neurobiology of Depression. Neurobiology of Depression 27 56 .
Alexander S. Korb, Aimee M. Hunter, Ian A. Cook & Andrew F. Leuchter. (2011) Rostral anterior cingulate cortex activity and early symptom improvement during treatment for major depressive disorder. Psychiatry Research: Neuroimaging 192:3, pages 188-194.
Crossref
André Tadić, Stefanie Wagner, Konrad Friedrich Schlicht, Dirk Peetz, Liudmyla Borysenko, Nadine Dreimüller, Christoph Hiemke & Klaus Lieb. (2011) The early non-increase of serum BDNF predicts failure of antidepressant treatment in patients with major depression: A pilot study. Progress in Neuro-Psychopharmacology and Biological Psychiatry 35:2, pages 415-420.
Crossref
Aimee M. Hunter, Ian A. Cook & Andrew F. Leuchter. (2010) Impact of Antidepressant Treatment History on Clinical Outcomes in Placebo and Medication Treatment of Major Depression. Journal of Clinical Psychopharmacology 30:6, pages 748-751.
Crossref
Andrew F. Leuchter, Ian A. Cook, Steven P. Hamilton, Katherine L. Narr, Arthur Toga, Aimee M. Hunter, Kym Faull, Julian Whitelegge, Anne M. Andrews, Joseph Loo, Baldwin Way, Stanley F. Nelson, Steven Horvath & Barry D. Lebowitz. (2010) Biomarkers to Predict Antidepressant Response. Current Psychiatry Reports 12:6, pages 553-562.
Crossref
Andrew F. Leuchter & Ian A. Cook. (2010) Reply to Kuo and Tsai. Psychiatry Research 180:1, pages 61-62.
Crossref
David Brent, Nadine Melhem & Gustavo Turecki. (2010) Pharmacogenomics of suicidal events. Pharmacogenomics 11:6, pages 793-807.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.